Table 6 Analysis of marketed formulation
From: Stability-indicating HPLC-DAD method for the determination of empagliflozin
Marketed formulation | Recovered amount | Claimed amount (mg) | ||
|---|---|---|---|---|
Amount found (mg) | Recovery(%) ± SD* | RSD* (%) | ||
Formulation 1 (Empagliflozin 25 mg, excipients qs) | 24.97 | 99.90 ± 0.258 | 0.258 | 25 |
Formulation 2 (Empagliflozin 25 mg, excipients qs) | 24.98 | 99.94 ± 0.240 | 0.240 | 25 |